NCT04530513View on ClinicalTrials.gov

ARREST - A Phase I Study of SABR for Poly-metastatic Disease

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

June 26, 2023

Study Completion Date

June 15, 2025

Conditions
Metastatic Cancer
Interventions
RADIATION

Stereotactic ablative radiotherapy - Level 1

6Gy x 2 fractions to all sites in 2 weeks

RADIATION

Stereotactic ablative radiotherapy - Level 2

6Gy x 3 fractions to all sites in 3 weeks

RADIATION

Stereotactic ablative radiotherapy - Level 3

6Gy x 4 fractions to all sites in 4 weeks

RADIATION

Stereotactic ablative radiotherapy - Level 4

6Gy x 5 fractions to all sites in 5 weeks

RADIATION

Stereotactic ablative radiotherapy - De-escalation Level

6Gy x 1 fraction to all sites in 1 week

Trial Locations (1)

N6A 5W9

London Health Sciences Centre - London Regional Cancer Program, London

Sponsors
All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER